RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 62 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -97.3% | 29,400 | -94.8% | 0.00% | -100.0% |
| Q2 2022 | $479,000 | -65.9% | 563,400 | +121.1% | 0.00% | -75.0% |
| Q1 2022 | $1,404,000 | -32.2% | 254,800 | +19.2% | 0.00% | -20.0% |
| Q4 2021 | $2,070,000 | -19.2% | 213,800 | +49.2% | 0.01% | -28.6% |
| Q3 2021 | $2,562,000 | +226.0% | 143,300 | +345.0% | 0.01% | +250.0% |
| Q2 2021 | $786,000 | +147.2% | 32,200 | +168.3% | 0.00% | +100.0% |
| Q1 2021 | $318,000 | +67.4% | 12,000 | -52.0% | 0.00% | 0.0% |
| Q4 2020 | $190,000 | +45.0% | 25,000 | -4.6% | 0.00% | – |
| Q3 2020 | $131,000 | -28.0% | 26,200 | -13.8% | 0.00% | -100.0% |
| Q2 2020 | $182,000 | +46.8% | 30,400 | +9.0% | 0.00% | – |
| Q1 2020 | $124,000 | – | 27,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $41,187,000 | 42.64% |
| Flagship Pioneering Inc. | 38,296,526 | $602,404,000 | 26.08% |
| HARBOURVEST PARTNERS LLC | 1,973,756 | $31,048,000 | 5.81% |
| Artal Group S.A. | 2,833,791 | $44,576,000 | 1.80% |
| EcoR1 Capital, LLC | 463,152 | $7,285,000 | 0.74% |
| Cormorant Asset Management, LP | 600,000 | $9,438,000 | 0.54% |
| Nikko Asset Management Americas, Inc. | 1,254,158 | $19,728,000 | 0.39% |
| Leap Investments LP | 14,100 | $222,000 | 0.30% |
| ARK Investment Management | 698,402 | $10,986,000 | 0.28% |
| Baillie Gifford | 4,234,682 | $66,612,000 | 0.07% |